Antidiabetic drugs reduce food intake: Are GLP-1 receptor agonists the new magic bullet in metabolic disease or are there risks involved?

Order Description

Literature Project

A completed title page
Table of contents
Main chapters/sections
Formatted list of references

Paper should discuss GLP-1 therapeutic capabilities:pros and cons as well as comparison to DPP-4 for the last section.